Surgical management for overactive bladder

Current Bladder Dysfunction Reports

Volumn 2, Issue 1, 2007, Pages 37-45

  Appell, Rodney A ^a   Boone, Timothy B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959329406     PISSN: 19317212     EISSN: 19317220     Source Type: Journal    
DOI: 10.1007/s11884-007-0032-x     Document Type: Article

References (49)

1. Hanno PM, Wein AJ: Interstitial cystitis. J Urol 1987, 138: 595-596.
2. Hanno PM, Wein AJ: Conservative therapy of interstitial cystitis. Semin Urol 1991, 9: 143-147.
3. Rofeim O, Shupp-Byme D, Mulholland GS, et al.: The effects of hydrodistention on bladder surface mucin. Urology 2001, 57: 130-132.
4. Chai TC, Zhang CO, Shoenfelt JL, Johnson HW Jr, et al.: Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis. J Urol 2000, 163: 1440-1444.
5. Ingelman-Sundberg A: Partial denervation of the bladder. A new operation for the treatment of urge incontinence and similar conditions in women: Acta Obst Gynecol Scand 1959, 38: 487-490.
6. Cespedes RD, Cross CA, McGuire EJ: Modified Ingelman-Sundberg bladder denervation procedure for intractable urge incontinence: J Urol 1996, 156: 1744-1747.
7. Susset JG, Pinheiro, J, Otton P, et al.: Selective phenolization and neurotomy in the treatment of neurogenic bladder dysfunction due to an incomplete central lesion [in French]: J Urol Nephrol (Paris) 1969, 75(Suppl 12): 502-504.
8. Blackford HN, Murray K, Stephenson TP, et al.: Results of transvesical infiltration of the pelvic plexuses with phenol in 116 patients. Br J Urol 1984, 56: 647-649.
9. Harris RG, Constantinou CE, Stamey TA: Extravesical subtrigonal injection of 50 per cent ethanol for detrusor instability. J Urol 1988, 140: 111-116.
10. Ramsay IN, Clancy S, Hilton P: Subtrigonal phenol injections in the treatment of idiopathic detrusor instability in the female-a long-term urodynamic follow-up. Br J Urol 1992, 69: 363-365.
11. McInerney PD, Vanner TF, Matenhelia S, et al.: Assessment of the long-term results of subtrigonal phenolization. Br J Urol 1991, 67: 586-587.
12. Madjar S, Smith D, Balzarro M, Appell RA: Bupivacaine Injections Prior to subtrigonal Phenolization: Preliminary Results [abstract]. J Urol 2001, 165(Suppl): 277.
13. Bennani S: Evaluation of sub-trigonal injections in the treatment of the hyperactive bladder [in French]. Ann Urol (Paris) 1994, 28: 13-19.
14. Worth PH: The treatment of interstitial cystitis by cystolysis with observations on cystoplasty. A review after 7 years. Br J Urol 1980, 52: 232-235.
15. Freiha FS, Stamey TA: Cystolysis: a procedure for the selective denervation of the bladder. J Urol 1980, 123: 360-363.
16. Caldwell K: The electrical control of sphincter incompetence. Lancet 1963, 2: 174-175.
17. Vodusek DB, Light JK, Libby JM: Detrusor inhibition induced by stimulation of pudendal nerve afferents. Neurourol Urodyn 1986, 5: 381-384.
18. Zvara P, Sahi S, Hassouna MM: An animal model for the neuromodulation of neurogenic bladder dysfunction. Br J Urol 1998, 82: 267-271.
19. Fall M, Lindstrom S: Electrical stimulation. A physiologic approach to the treatment of urinary incontinence. Urol Clin N Amer 1991, 18: 393-407.
20. McGuire EJ, Zhang SC, Horwinski ER, et al.: Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol 1983, 129: 78-79.
21. Klingler HC, Pycha A, Schmidbauer J, et al.: Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology 2000, 56: 766-771.
22. Govier FE, Litwiller S, Nitti V, et al.: Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol 2001, 165: 1193-1198.
23. Juenemann KP, Lue TF, Schmidt RA, et al.: Clinical significance of sacral and pudendal nerve anatomy. J Urol 1988, 139: 74-80.
24. Koldewijn EL, Rosier PF, Meuleman EJ, et al.: Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients. J Urol 1994, 152: 2071-2075.
25. Janknegt RA, Hassouna MM, Siegel SW, et al.: Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol 2001, 39: 101-106.
26. Schurch B, Stohrer M, Kramer G, et al.: Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000, 164: 692-697.
27. Grosse J, Kramer G, Stohrer M: Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrosor overactivity and incontinence. Eur Urol 2005, 47: 653-659.
28. Leippold T, Reitz A, Schurch B: Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol 2003, 44: 165-174.
29. Rapp DE, Lucioni A, Katz EE, et al.: Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 2004, 63: 1071-1075.
30. Cartwright PC, Snow BW: Bladder autoaugmentation: early clinical experienceJ Urol 1989, 142: 505-508.
31. Swami KS, Feneley RC, Hammonds JC, et al.: Detrusor myectomy for detrusor overactivity: a minimum 1-year follow-up. Br J Urol 1998, 81: 68-72.
32. Stohrer M, Goepel M, Kramer G, et al.: Detrusor myectomy (autoaugmentation) in the treatment of hyper-reflexive low compliance bladder [in German]. Urology A 1999, 38: 30-37.
33. Siracusano S, Trombetta C, Liguori G, et al.: Laparoscopic bladder auto-augmentation in an incomplete traumatic spinal cord injury. Spinal Cord 2000, 38: 59-61.
34. Kennelly MJ, Gormley EA, McGuire EJ: Early clinical experience with adult bladder auto-augmentation. J Urol 1994, 152: 303-306.
35. Leng WW, Blalock HJ, Fredriksson WH, et al.: Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J Urol 1999, 161: 758-763.
36. Goodwin WE, Winter CC: Results of ileocystoplasty. J Urol 1958, 80: 461-466.
37. Christmas TJ, Holmes SA, Hendry WF: Bladder replacement by ileocystoplasty: the final treatment for interstitial cystitis. Br J Urol 1996, 78: 69-73.
38. Baskin LS, Tanagho EA: Pelvic pain without pelvic organs. J Urol 1992, 147: 683-686.
39. Mundy AR, Stephenson TP: "Clam" ileocystoplasty for the tretment of refractory urge incontinence. Br J Urol 1985, 57: 641-646.
40. Goldwasser B, Webster GD: Augmentation and substitution enterocystoplasty. J Urol 1986, 135: 215-224.
41. Awad SA, Al-Zahrani HM, Gajewski JB, et al.: Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 1998, 81: 569-573.
42. Flood HD, Malhotra SJ, O'Connell HE, et al.: Long-term results and complications using augmentation cystoplasty in reconstructive urology. Neurourol Urodyn 1995, 14: 297-309.
43. King LR, Stone AR, Webster GD, eds: Cystoplasty in Children. In Bladder Reconstruction and Continent Urinary Diversion, edn 2. St. Louis: Mosby; 1991: 115-125.
44. Wood GA, Heathcote PS, Nicol DL: Bowel motility after enterocystoplasty. Br J Urol 1998, 81: 565-568.
45. Goldwasser B, Barrett DM, Webster GD, et al.: Cystometric properties of ileum and right colon after bladder augmentation, substitution or replacement. J Urol 1987, 138: 1007-1008.
46. Koch MO, McDougal WS, Hall MC, et al.: Long-term metabolic effects of urinary diversion: a comparison of myelomeningocele patients managed by clean intermittent catheterization and urinary diversion. J Urol 1992, 147: 1343-1347.
47. Filmer RB, Spencer JR: Malignancies in bladder augmentations and intestinal conduits. J Urol 1990, 143: 671-678.
48. Gillon G, Mundy AR: The dissolution of urinary mucus after cystoplasty. Br J Urol 1989, 63: 372-374.
49. Elder JS, Snyder HM, Hulbert WC, Duckett JW: Perforation of the augmented bladder in patients undergoing clean intermittent catheterization. J Urol 1988, 140: 1159-1162.